BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4843684)

  • 1. Proceedings: Treatment of multiple myeloma by a quadruple chemotherapy regime.
    Azam L; Delamore IW
    Br J Haematol; 1974 Jun; 27(2):362. PubMed ID: 4843684
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of plasmacytoma therapy of ALGB (acute leukemia group B)].
    Obrecht JP
    Hamatol Bluttransfus; 1976; 18():383-93. PubMed ID: 964714
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug - resistant multiple myeloma. A trial with the M 2 cyclic alkylating agent polychemotherapy.
    Buonanno G; Tortarolo M; Valente A; Castaldo C; Russolillo S; Gonnella F
    Haematologica; 1978 Feb; 63(1):45-55. PubMed ID: 417971
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of Kahler's disease].
    Foa J; Carcassonne Y
    Sem Hop; 1976 Jan; 52(3):165-71. PubMed ID: 186874
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapy of multiple myeloma. Review of the recent trials].
    Tribalto M; Arcese W; Colombo R; Pastore S; Franchii A
    Recenti Prog Med; 1981 Aug; 71(2):141-7. PubMed ID: 7031807
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recent progress in chemotherapy of multiple myeloma].
    Tortarolo M; Cantore N; Russolillo S; Castaldo C; Buonanno G
    Recenti Prog Med; 1978 Jul; 65(1):44-68. PubMed ID: 370935
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) (author's transl)].
    Bataille R; Morlock G; Rosenberg F; Sany J; Serre H
    Sem Hop; 1979 Sep 18-25; 55(31-32):1377-82. PubMed ID: 228415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Protracted pulse" chemotherapy for refractory myeloma: a preliminary report.
    Manoharan A
    Eur J Haematol; 1990 Nov; 45(5):274-5. PubMed ID: 2261956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis and treatment of generalized plasmacytoma (multiple myeloma)].
    Andreeva NE; Antipova LG
    Ter Arkh; 1977; 49(8):76-85. PubMed ID: 929397
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.
    Lee BJ; Sahakian G; Clarkson BD; Krakoff IH
    Cancer; 1974 Feb; 33(2):533-8. PubMed ID: 4812771
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
    Iwata Y; Karitani Y; Tanaka I; Kobayashi T; Ohno T; Kageyama S; Katayama N; Kataoka Y; Kamio N; Ohota C
    Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy for myelomatosis.
    Azam L; Delamore IW
    Br Med J; 1974 Dec; 4(5944):560-4. PubMed ID: 4611585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a cooperative group human myeloma protocol using the MOPC 104E myeloma model.
    Hiramoto R; Ghanta V; Durant JR
    Cancer Res; 1975 May; 35(5):1309-13. PubMed ID: 1120314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the status of the nitrosoureas in other tumors.
    Carter SK
    Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
    [No Abstract]   [Full Text] [Related]  

  • 15. Pseudohypercalcemia and hyperviscosity with neurological manifestations in multiple myeloma.
    van Dijk JM; Sonnenblick M; Weissberg N; Rosin A
    Isr J Med Sci; 1986 Feb; 22(2):143-4. PubMed ID: 3753959
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
    Snigurowicz J; Kraj M; Rostkowska J; Maj S; Mariańska B; Mendek E; Roszkowski S; Kilian Z; Kołakowski L
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):145-53. PubMed ID: 7030265
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of the tumor cell mass and its significance as a parameter for prognosis and therapy in patients with multiple myeloma].
    Ludwig H; Schneider K; Pietschmann H
    Acta Med Austriaca; 1978; 5(4-5):164-6. PubMed ID: 756132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study on chemotherapy for multiple myeloma. Part II: Prognostic factors of treatment with prednisolone and sequential melphalan and ifosfamide: MIP therapy].
    Sezaki T; Ishii H; Adachi T; Takahashi I; Ohnoshi T; Kimura I
    Rinsho Ketsueki; 1983 Apr; 24(4):433-9. PubMed ID: 6887543
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study on the chemotherapy of multiple myeloma. 1. Therapeutic effect of sequential combination therapy using melphalan, ifosfamide, and prednisolone].
    Sezaki T; Ishii H; Osada T; Adachi T; Takahashi I; Ohnoshi T; Kimura I
    Rinsho Ketsueki; 1982 Jun; 23(6):847-53. PubMed ID: 7176091
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor proliferation and chemotherapy in immunosuppressed mice.
    Ghanta VK; Shrestha K; Durant JR; Hiramoto RN
    Cancer Res; 1983 Mar; 43(3):1097-100. PubMed ID: 6825081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.